Nivestym

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Aug 12, 2025
Approval ID: d23ab39c-b6ec-41cf-a529-9dd2852c9d9a
Products: 4 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NIVESTYM safely and effectively. See full prescribing information for NIVESTYM. NIVESTYM™ (filgrastim-aafi) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2018 NIVESTYM (filgrastim-aafi) is biosimilar to NEUPOGEN (filgrastim).

Quick Stats

Total Products4

Labelers2

Label Sections47

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.